Please Wait
Applying Filters...
menu
    • menu

    Company Digital Content of Capital Farma

    Capital Farma-PSE
    News
    FDA approves Astellas' gastric cancer therapy

    19 Oct 2024

    // REUTERS

    Gilead withdraws bladder cancer drug in US after failed trial

    19 Oct 2024

    // REUTERS

    Europe's CHMP backs Novo's FDA-rejected hemophilia treatment

    19 Oct 2024

    // FIERCE PHARMA

    Data Compilation
    #PharmaFlow

    Capital Farma

    Contact Supplier

    Website

    AAPS 2024

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Capital Farma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/capital-farma-party-content-20144.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare
    Contact Capital Farma and get a quotation

    Capital Farma is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Galantamine Hydrobromide bulk offered by Capital Farma

    Find a price of Silver Sulfadiazine bulk offered by Capital Farma